Recent Finacing
Recent Raise
Cytoki Pharma is a Copenhagen-based biotech developing lipidated, long-acting synthetic IL-22 protein therapeutics (licensed from Novo Nordisk) to promote epithelial repair, targeting ulcerative colitis, Crohn’s disease, and liver injury.
